Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia
Georgia Koutsoumpli(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center), Nina C. Groenland(Leiden University Medical Center), Rob C. M. de Jong(Leiden University Medical Center), Dyantha I. van der Lee(Leiden University Medical Center), Dominik Lock(Miltenyi Biotec (Germany)), Hendrik Veelken(University of Freiburg), Mirjam H.M. Heemskerk(Leiden University Medical Center), JH Falkenburg(Leiden University), Renate S. Hagedoorn(Leiden University Medical Center), Peter A. van Veelen(Leiden University Medical Center), M. Willy Honders(Leiden University Medical Center), Ian Johnston(University of Pennsylvania)
Cited by 0
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Essential role of stromally induced hedgehog signaling in B-cell malignancies
|Nature Medicine|2007|321
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
|Journal of Clinical Investigation|2019|232
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
|Nature Immunology|2021|130
Genomic reconstruction of the SARS-CoV-2 epidemic in England
|Nature|2021|120